Back

Non-valvular atrial fibrillation (AF) and coronary artery disease with percutaneous revascularisation: safety of triple therapy with dabigatran

3 March 2019 (09:00 - 17:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Cardiovascular Pharmacotherapy Anticoagulants ACVC Premium Access Acute Cardiovascular Care 2019

About the speaker

Photo
Doctor Macarena Cano-Garcia

Regional University Hospital Carlos Haya, Malaga (Spain)

6 More presentations in this session

Presentation thumbnail
Doctor S. Salahia (Cairo, EG)
Presentation thumbnail
Doctor A. Marques (Almada, PT)
Abstract Slides
Presentation thumbnail
Doctor A. Marques (Almada, PT)
Abstract Slides
Presentation thumbnail
Doctor M. Coutinho Cruz (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Doctor E. Pogran (Vienna, AT)

Access the full session

Session thumbnail
Poster Session 2 - Cardiovascular Pharmacotherapy

The Event

Event poster

Acute Cardiovascular Care 2019

3 March 2019 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Meta-analysis of clinical trials comparing triple versus dual antithrombotic therapy on risk reduction of stent thrombosis after percutaneous coronary intervention in atrial fibrillation patients
27 August 2021
thumbnail
Congress Presentation
Oral anticoagulation in 13,344 adult patients with congenital heart disease (ACHD) in a longitudinal real-world setting in 2005-2017
2 September 2019
thumbnail
Congress Presentation
Comparison of efficacy of different anticoagulation strategies used during pulmonary vein isolation in left atrial blood samples
1 September 2019
thumbnail
Congress Presentation
Efficacy and safety of clopidogrel, ticagrelor, and prasugrel in an all-comers population of patients with ST-segment elevation myocardial infarction
31 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources